End Of An Era: MHRA’s Wilkinson On Record Over Creating Brexit-Proof Devices Section At MHRA
Executive Summary
John Wilkinson talks to Medtech Insight about his legacy, Brexit issues and how he sees the UK regulatory system evolving when he leaves in October this year, after seven years as head of devices at the MHRA.
You may also be interested in...
Raine To Lead UK MHRA Ahead Of Permanent Head Announcement
June Raine has agreed to lead the Medicines and Healthcare products Regulatory Agency temporarily after the agency’s incumbent chief executive steps down in September.
Opinion: Wilkinson’s October Departure From UK MHRA – Should We Be Concerned?
The MHRA’s John Wilkinson has arguably been the most high-profile medtech regulator in Europe this decade. Who replaces him and how the UK goes forward are matters of not just national, but also European and international importance, says Medtech Insight’s Amanda Maxwell. Three key regulatory officials add their views too.
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.